Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor StrokeEleonora De Matteis, Giampietro Ruzza, Valentina Saia et al.|Stroke|2023Cited by 34
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study CohortRaffaele Ornello, Simone Beretta, Matteo Foschi et al.|Journal of the American Heart Association|2024Cited by 12
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countriesAnita van de Munckhof, A. R. Baños, Ahmed Elkady et al.|International Journal of Stroke|2023Cited by 8
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Daniele Orsucci, Lucio D’Anna et al.|Stroke|2024Cited by 5
ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case–control studyGie Ken‐Dror, Maria Sofia Cotelli, Pankaj Sharma et al.|Journal of the Royal Society of Medicine|2023Cited by 3